Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | IMA101 T cells |
Synonyms | |
Therapy Description |
IMA101 T cells are autologous cytotoxic T lymphocytes that are expanded ex vivo and injected back into the patient with the potential to recognize specific tumor-associated antigens on cancer cells and subsequently, induce cell death (NCI Drug Dictionary). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
IMA101 T cells | ACTolog IMA101|IMA101 | IMA101 T cells are autologous cytotoxic T lymphocytes that are expanded ex vivo and injected back into the patient with the potential to recognize specific tumor-associated antigens on cancer cells and subsequently, induce cell death (NCI Drug Dictionary). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|